Clinical Trial Update: Dual Target CAR-T Cells in B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for dual-target CAR-T cells in B-cell lymphoma is ongoing, with the sponsor listed and the status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Or Refractory B-cell Lymphoma

Drugs mentioned

• Dual-target CAR-T cells (null)

Snippet

Sponsor: YuLi | Conditions: Lymphoma, B-Cell, Relapse/Recurrence | Phase 1, Phase 2 | Status: UNKNOWN